PROTAC erf3a Degrader-1

Overview

PROTAC erf3a Degrader-1 (Compound C63) is an orally active PROTAC erf3a Degrader. PROTAC erf3a Degrader-1 inhibits cancer cell proliferation (eg: 22Rv1). PROTAC erf3a Degrader-1 can be used for research of prostate cancer , ovarian cancer , liver cancer , cervical cancer , leukemia, breast cancer . (Pink: eRF3a/GSPT1 Target protein ligand; Blue: Cereblon ligand ( HY-41547 ); Black: linker ( HY-163960 )).

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PROTACs | Products > Signaling Pathways > Eukaryotic Release Factor (eRF)

Product Information

• Catalog No.: HY-163938
• CAS No.: 3033871-19-8
• Molecular Formula: C44H52N6O6
• Molecular Weight: 760.92
• Purity: 99.44%
• Storage: -20°C, protect from light, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
• Availability: In-stock

Source

Original product source